Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Microba Life Sciences and Ginkgo Bioworks Announce Partnership to Discover Novel Live Biotherapeutics
Microba Life Sciences (ASX:MAP), a precision microbiome science company, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform […]
Healthtech Company Paindrainer AB Recruits New CEO with Experience from Commercialization of Digital Services
Erik Frick is taking over as new CEO of PainDrainer AB with the task of […]
CardioRenal Raises €3.3 million
CardioRenal, a company specialized in improving treatment at home for patients with severe chronic kidney […]
Arrayjet Introduces Mercury Range of Next-generation Microarray Printers
Arrayjet, a leading provider of inkjet liquid-handling solutions, today introduced Mercury, a new core range of […]
Major New Review of Health Inequalities Lays Roadmap For The Role of Business in Levelling Up
A major review of health inequities published today, 4th April, lays a roadmap for the […]
U.S. FDA Grants Priority Review to Roche’s Actemra/Roactemra for the Treatment of COVID-19 in Hospitalised Adults
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration […]
Dexcom ONE on NHS Prescription Following NICE Diabetes Guidelines
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced […]
Orbia's Koura Business Opens World's First HFA 152a Medical Propellant Production Facility
Koura, a global leader in the development, manufacture, and supply of fluoroproducts and technologies,[2] today opens […]
NHS Runs World-first Test into ‘Sci-Fi Like’ Artificial Pancreases
Almost 1,000 adults and children with type 1 diabetes have been given a potentially life-altering […]
HMNC Brain Health and Develco Pharma Announce Promising Preliminary Results in Treatment-resistant Depression (TRD)
HMNC Brain Health (“HMNC” or the “Company”), a global clinical stage biopharmaceutical company pioneering the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more